Evidence map›Paper›PMID 25444929›Full record

ArticleCancer letters2015

Tyrosine phosphorylation of HSC70 and its interaction with RFC mediates methotrexate resistance in murine L1210 leukemia cells.

Tuoen Liu, Ratan Singh, Zechary Rios, Alok Bhushan, Mengxiong Li, Peter P Sheridan, Shawn E Bearden, James C K Lai, Senyo Agbenowu, Shousong Cao and 1 more

Open access · greenAbstract read
In one paragraph

Article in Cancer letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Tuoen LiuDepartment of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, United States.
Ratan SinghDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID, United States.
Zechary RiosDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID, United States.
Alok BhushanDepartment of Pharmaceutical Sciences, Jefferson School of Pharmacy, Thomas Jefferson University, Philadelphia, PA, United States.
Mengxiong LiGynecological Department, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China.
Peter P SheridanDepartment of Biological Sciences, Idaho State University, Pocatello, ID, United States; The ISU Biomedical Research Institute, Idaho State University, Pocatello, ID, United States.
Shawn E BeardenDepartment of Biological Sciences, Idaho State University, Pocatello, ID, United States; The ISU Biomedical Research Institute, Idaho State University, Pocatello, ID, United States.
James C K LaiDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID, United States; The ISU Biomedical Research Institute, Idaho State University, Pocatello, ID, United States.
Senyo AgbenowuDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID, United States.
Shousong CaoChifeng Saliont Pharmaceutical Co., Ltd., 228 North Qinghe Road, Hongshan District, Chifeng, Inner Mongolia Autonomous Region 024000, China. Electronic address: shousongc@gmail.com.
Christopher K DanielsDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID, United States; The ISU Biomedical Research Institute, Idaho State University, Pocatello, ID, United States. Electronic address: cdaniels@pharmacy.isu.edu.
Idaho State University · USChifeng University · CNSun Yat-sen University · CNThomas Jefferson University · USWashington University in St. Louis · US

Funding

Women's health: interplay of maternal diet and key demographics on neurological health in the rural frontier and remote WestP20GM103408 · NIGMS · UNIVERSITY OF IDAHO · PI Scott A Minnich · 2012 to 2026
$59.8M
UNDERGRADUATE COLLEGE OUTREACH PROGRAMP20RR016454 · NCRR · UNIVERSITY OF IDAHO · PI CHASE, JENNIFER R · 2001 to 2011
$35.3M
NCRR NIH HHS P20 RR016454NCRR NIH HHS P20 RR16454NIGMS NIH HHS P20 GM103408
6 · The paper itself

Abstract

We previously identified and characterized a 66-68 kDa membrane-associated, tyrosine phosphorylated protein in murine leukemia L1210 cells as HSC70 which is a methotrexate (MTX)-binding protein. In order to further characterize the functional role of HSC70 in regulating MTX resistance in L1210 cells, we first showed that HSC70 colocalizes and interacts with reduced folate carrier (RFC) in L1210 cells by confocal laser scanning microscopy and Duolink in situ proximity ligation assay. The tyrosine phosphorylation status of HSC70 found in the membrane fraction was different from the parental L1210/0 and cisplatin (CDDP)-MTX cross resistant L1210/DDP cells. In MTX-binding assays, HSC70 from L1210/DDP cells showed less affinity for MTX-agarose beads than that of L1210/0 cells. In addition, genistein (a tyrosine phosphorylation inhibitor) significantly enhanced the resistance of L1210/0 cells to MTX. Moreover, site-directed mutation studies indicated the importance of tyrosine phosphorylation of HSC70 in regulating its binding to MTX. These findings suggest that tyrosine phosphorylation of HSC70 regulates the transportation of MTX into the cells via the HSC70-RFC system and contributes to MTX resistance in L1210 cells.

Indexed as

AnimalsDrug Resistance, NeoplasmHSC70 Heat-Shock ProteinsLeukemia L1210MethotrexateMiceMicroscopy, ConfocalPhosphorylationReduced Folate Carrier ProteinTyrosineHSC70 Heat-Shock ProteinsMethotrexateReduced Folate Carrier ProteinTyrosineCross resistanceHeat shock cognate protein 70Methotrexate binding proteinMethotrexate transportationReduced folate carrierTyrosine phosphorylation

Identifiers

PMID25444929
PMCPMC4785865
OpenAlexW2041121213

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.